Author

Tanuza Nazmul

Hiroshima UniversityORCID 0000-0002-5889-5703Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Hidemasa U. BonoiD· 1 shared Keiji TanimotoiD· 1 shared Kiichi HirotaiD· 1 shared Nobuyuki HirohashiiD· 1 shared Takahiro Fukazawa· 1 shared Takemasa SakaguchiiD· 1 shared Toshihito NomuraiD· 1 shared Yoshiyuki MatsuoiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Hidemasa U. BonoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal

Keiji Tanimoto, Kiichi Hirota, Takahiro Fukazawa, Yoshiyuki Matsuo, Toshihito Nomura, Tanuza Nazmul, Nobuyuki Hirohashi, Hidemasa U. Bono, Takemasa Sakaguchi

This study shows that AHR agonists like CSE, FICZ, and OMP reduce ACE2 expression, inhibiting SARS-CoV-2 infection in mammalian cells.

Scientific Reports · Aug 17, 2021Peer-reviewedMolecular Biology